- Home
- TNXP vs ATER Comparison
TNXP vs ATER Comparison
Compare TNXP & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNXP | ATER |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.7M | 5.8M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TNXP | ATER |
|---|---|---|
| Price | $13.65 | $0.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 419.1K | 33.9K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.75 | 55.77 |
| EPS | N/A | ★ N/A |
| Revenue | $13,107,000.00 | ★ $68,975,000.00 |
| Revenue This Year | $558.11 | $16.48 |
| Revenue Next Year | $38.29 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.85 | N/A |
| 52 Week Low | $11.60 | $0.52 |
| 52 Week High | $69.65 | $2.14 |
Technical Indicators
Market Signals| Indicator | TNXP | ATER |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 60.02 |
| Support Level | $13.32 | $0.64 |
| Resistance Level | $20.36 | $0.74 |
| Average True Range (ATR) | 1.18 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 37.93 | 100.00 |
Price Performance
Historical ComparisonAbout TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.